Experienced in Paronychia

Dr. Zofia Piotrowska

Oncology | Infectious Disease | Hematology
The General Hospital Corporation
55 Fruit St, 
Boston, MA 
Accepting New Patients
Offers Telehealth
Experienced in Paronychia
The General Hospital Corporation
55 Fruit St, 
Boston, MA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Zofia Piotrowska is an Oncologist and an Infectious Disease provider in Boston, Massachusetts. Dr. Piotrowska is rated as an Experienced provider by MediFind in the treatment of Paronychia. Her top areas of expertise are EGFR Positive Lung Cancer, Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC), and Tissue Biopsy. Dr. Piotrowska is currently accepting new patients.

Her clinical research consists of co-authoring 84 peer reviewed articles and participating in 5 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 1 article in the study of Paronychia.

Specialties
Oncology
Infectious Disease
Hematology
Licenses
Internal Medicine in MA
Hospital Affiliations
Massachusetts General Hospital
Brigham And Women's Hospital
Languages Spoken
English
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Commonwealth Care Alliance
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Mass General Brigham Health Plan
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Tufts
  • HMO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 7 Less Insurance Carriers -

Locations

THE GENERAL HOSPITAL CORPORATION
55 Fruit St, Boston, MA 02114

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

A Phase 2 Study of Osimertinib in Combination With Selumetinib in EGFR Inhibitor naïve Advanced EGFR Mutant Lung Cancer
A Phase 2 Study of Osimertinib in Combination With Selumetinib in EGFR Inhibitor naïve Advanced EGFR Mutant Lung Cancer
Enrollment Status: Active_not_recruiting
Publish Date: July 15, 2025
Intervention Type: Drug
Study Drugs: Osimertinib, Selumetinib
Study Phase: Phase 2
A Phase 2 Study of EGF816 and Gefitinib in TKI-naïve EGFR-mutant Non-Small Cell Lung Cancer
A Phase 2 Study of EGF816 and Gefitinib in TKI-naïve EGFR-mutant Non-Small Cell Lung Cancer
Enrollment Status: Terminated
Publish Date: June 10, 2025
Intervention Type: Drug
Study Drugs: EGF816, Gefitinib
Study Phase: Phase 2
A Randomized Phase 3 Multicenter Open-Label Study to Compare the Efficacy of TAK-788 as First-Line Treatment Versus Platinum-Based Chemotherapy in Patients With Non-Small Cell Lung Cancer With EGFR Exon 20 Insertion Mutations
A Randomized Phase 3 Multicenter Open-Label Study to Compare the Efficacy of TAK-788 as First-Line Treatment Versus Platinum-Based Chemotherapy in Patients With Non-Small Cell Lung Cancer With EGFR Exon 20 Insertion Mutations
Enrollment Status: Active_not_recruiting
Publish Date: April 22, 2025
Intervention Type: Drug
Study Drugs: TAK-788, Pemetrexed, Cisplatin, Carboplatin
Study Phase: Phase 3
A Phase 1/2, Open-Label, Multi-Center Trial to Assess Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of CLN-081 in Patients With Locally-Advanced or Metastatic Non-Small Cell Lung Cancer Harboring EGFR Exon 20 Insertion Mutations Who Have Previously Received Platinum-Based Systemic Chemotherapy
A Phase 1/2, Open-Label, Multi-Center Trial to Assess Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of CLN-081 in Patients With Locally-Advanced or Metastatic Non-Small Cell Lung Cancer Harboring EGFR Exon 20 Insertion Mutations Who Have Previously Received Platinum-Based Systemic Chemotherapy
Enrollment Status: Active_not_recruiting
Publish Date: March 13, 2025
Intervention Type: Drug
Study Drug: CLN-081
Study Phase: Phase 1/Phase 2
Rapid Plasma Genotyping For Early Initiation Of Erlotinib In EGFR Mutant Lung Cancer
Rapid Plasma Genotyping For Early Initiation Of Erlotinib In EGFR Mutant Lung Cancer
Enrollment Status: Terminated
Publish Date: November 22, 2019
Intervention Type: Drug
Study Phase: Phase 2
View 4 Less Clinical Trials

84 Total Publications

Clinical factors and molecular co-alterations impact outcomes in patients receiving first-line osimertinib for EGFR-mutated non-small cell lung cancer.
Clinical factors and molecular co-alterations impact outcomes in patients receiving first-line osimertinib for EGFR-mutated non-small cell lung cancer.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: June 08, 2025
Similar Doctors
Experienced in Paronychia
Dr. Laura Kogelman
Infectious Disease
Experienced in Paronychia
Dr. Laura Kogelman
Infectious Disease

Pratt Medical Group Inc

800 Washigton St, 
Boston, MA 
 (0.9 miles away)
617-636-5000
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Laura Kogelman is an Infectious Disease provider in Boston, Massachusetts. Dr. Kogelman is rated as a Distinguished provider by MediFind in the treatment of Paronychia. Her top areas of expertise are HIV/AIDS, Myelitis, AIDS Dysmorphic Syndrome, and Yellow Fever. Dr. Kogelman is currently accepting new patients.

Experienced in Paronychia
Dr. David G. Sidebottom
Infectious Disease
Experienced in Paronychia
Dr. David G. Sidebottom
Infectious Disease
295 Varnum Ave, 
Lowell, MA 
 (24.1 miles away)
978-937-6000
Languages Spoken:
English
See accepted insurances
Accepting New Patients

David Sidebottom is an Infectious Disease provider in Lowell, Massachusetts. Dr. Sidebottom is rated as a Distinguished provider by MediFind in the treatment of Paronychia. His top areas of expertise are Osteomyelitis, Sepsis, Osteomyelitis in Children, and Myelitis. Dr. Sidebottom is currently accepting new patients.

Experienced in Paronychia
Dr. Roger P. Clark
Infectious Disease
Experienced in Paronychia
Dr. Roger P. Clark
Infectious Disease

Brigham And Womens Physicians Organization Inc

1153 Centre St, 
Jamaica Plain, MA 
 (5.2 miles away)
617-983-7000
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Roger Clark is an Infectious Disease provider in Jamaica Plain, Massachusetts. Dr. Clark is rated as an Experienced provider by MediFind in the treatment of Paronychia. His top areas of expertise are Osteomyelitis, Infectious Arthritis, Osteomyelitis in Children, and Chronic Recurrent Multifocal Osteomyelitis. Dr. Clark is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Piotrowska's expertise for a condition
ConditionClose
    View All 13 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile